Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Fine mapping of the HLA locus in Parkinson’s disease in Europeans

View ORCID ProfileEric Yu, Aditya Ambati, Maren Stolp Andersen, View ORCID ProfileLynne Krohn, View ORCID ProfileMehrdad A. Estiar, Prabhjyot Saini, View ORCID ProfileKonstantin Senkevich, Yuri L. Sosero, View ORCID ProfileAshwin Ashok Kumar Sreelatha, View ORCID ProfileJennifer A. Ruskey, Farnaz Asayesh, View ORCID ProfileDan Spiegelman, View ORCID ProfileMathias Toft, View ORCID ProfileMarte K. Viken, the International Parkinson’s Disease Genomics Consortium (IPDGC), Manu Sharma, View ORCID ProfileCornelis Blauwendraat, View ORCID ProfileLasse Pihlstrøm, View ORCID ProfileEmmanuel Mignot, View ORCID ProfileZiv Gan-Or
doi: https://doi.org/10.1101/2020.10.29.20217059
Eric Yu
1Department of Human Genetics, McGill University, Montréal, QC, Canada
2Montreal Neurological Institute and Hospital, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eric Yu
Aditya Ambati
3Stanford Center For Sleep Sciences and Medicine, Dept of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maren Stolp Andersen
4Department of Neurology, Oslo University Hospital, Oslo, Norway
5Institute of Clinical Medicine, University of Oslo, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lynne Krohn
1Department of Human Genetics, McGill University, Montréal, QC, Canada
2Montreal Neurological Institute and Hospital, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lynne Krohn
Mehrdad A. Estiar
1Department of Human Genetics, McGill University, Montréal, QC, Canada
2Montreal Neurological Institute and Hospital, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mehrdad A. Estiar
Prabhjyot Saini
1Department of Human Genetics, McGill University, Montréal, QC, Canada
2Montreal Neurological Institute and Hospital, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Konstantin Senkevich
2Montreal Neurological Institute and Hospital, McGill University, Montréal, QC, Canada
6Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Konstantin Senkevich
Yuri L. Sosero
1Department of Human Genetics, McGill University, Montréal, QC, Canada
2Montreal Neurological Institute and Hospital, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashwin Ashok Kumar Sreelatha
7Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ashwin Ashok Kumar Sreelatha
Jennifer A. Ruskey
2Montreal Neurological Institute and Hospital, McGill University, Montréal, QC, Canada
6Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jennifer A. Ruskey
Farnaz Asayesh
2Montreal Neurological Institute and Hospital, McGill University, Montréal, QC, Canada
6Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan Spiegelman
2Montreal Neurological Institute and Hospital, McGill University, Montréal, QC, Canada
6Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dan Spiegelman
Mathias Toft
4Department of Neurology, Oslo University Hospital, Oslo, Norway
5Institute of Clinical Medicine, University of Oslo, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mathias Toft
Marte K. Viken
8Department of Medical Genetics, University of Oslo and Oslo University Hospital, Oslo, Norway
9Department of Immunology, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marte K. Viken
Manu Sharma
7Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cornelis Blauwendraat
10Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cornelis Blauwendraat
Lasse Pihlstrøm
4Department of Neurology, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lasse Pihlstrøm
Emmanuel Mignot
3Stanford Center For Sleep Sciences and Medicine, Dept of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emmanuel Mignot
  • For correspondence: mignot@stanford.edu ziv.gan-or@mcgill.ca
Ziv Gan-Or
1Department of Human Genetics, McGill University, Montréal, QC, Canada
2Montreal Neurological Institute and Hospital, McGill University, Montréal, QC, Canada
6Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ziv Gan-Or
  • For correspondence: mignot@stanford.edu ziv.gan-or@mcgill.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective Previous studies suggested a role for the immune system in Parkinson’s disease (PD), and one of the hits in recent genome-wide association studies (GWASs) of PD is within the human leukocyte antigen (HLA) locus. Several associations of different HLA genes have been suggested, yet it is not clear which associations are relevant for PD.

Methods We performed a thorough analysis of the HLA locus in 13,770 PD patients, 20,214 proxy-cases and 490,861 controls of European origin. We used GWAS data to impute HLA types and performed multiple regression models to examine the association of specific HLA types, different haplotypes and specific amino acid changes. We further performed conditional analyses to identify specific alleles or genetic variants that drive the association with PD.

Results Four HLA types were associated with PD after correction for multiple comparisons, HLA-DQA1*03:01, HLA-DQB1*03:02, HLA-DRB1*04:01 and HLA-DRB1*04:04. Haplotype analyses followed by amino-acid analysis and conditional analyses suggested that the association is protective and primarily driven by three specific amino acid polymorphisms present in most HLA-DRB1*04 subtypes - 11V, 13H and 33H (OR=0.87 95%CI=0.83-0.90, p<8.23×10−9 for all three variants). No other effects were present after adjustment for these amino acids.

Interpretation Our results suggest that specific variants in the HLA-DRB1 gene are associated with reduced risk of PD, providing additional evidence for the role of the immune system in PD. Although effect size is small and has no diagnostic significance, understanding the mechanism underlying this association may lead to identification of new targets for therapeutics development.

Competing Interest Statement

Dr. Mignot reports non-financial support from Idorsia Pharmaceuticals Ltd, personal fees from Jazz Pharmaceutical, personal fees from Alairion, personal fees from ALPCO, personal fees from INEXIA, personal fees from Merck, personal fees from Orexia, personal fees from Rhythm, personal fees from Sunovion, during the conduct of the study. Dr. Gan-Or reports personal fees from Idorsia, personal fees from Neuron23, personal fees from Handl Therapeutics, personal fees from Lysosomal Therapeutics Inc., personal fees from Deerfield, personal fees from Lighthouse, personal fees from Prevail Therapeutics, personal fees from Ono Therapeutics, personal fees from Denali, personal fees from Inception Sciences, outside the submitted work.

Funding Statement

This work was financially supported by grants from the Michael J. Fox Foundation, the Canadian Consortium on Neurodegeneration in Aging (CCNA), the Canada First Research Excellence Fund (CFREF), awarded to McGill University for the Healthy Brains for Healthy Lives initiative (HBHL), and Parkinson Canada. This research was also supported in part by the Intramural Research Program of the NIH, National institute on Aging. HLA sequencing of samples from the Oslo Parkinson disease study was supported by the Norwegian Parkinson Research Fund. PPMI, a public private partnership, is funded by the Michael J. Fox Foundation for Parkinson Research and funding partners, including Abbvie, Allergan, Amathus Therapeutics, Avid Radiopharmaceuticals, Biogen, BioLegend, Bristol Myers Squibb, Celgene, Denali Therapeutics, GE Healthcare, Genentech, GlaxoSmithKline, Golub Capital, Handl Therapeutics, Insitro, Janssen, Lilly, Lundbeck, Merck, Meso Scale Discovery, Neurocrine Biosciences, Pfizer, Piramal, Prevail Therapeutics, Roche, Sanofi Genzyme, Servier, Takeda, Teva, UCB, Verily and Voyager Therapeutics. This research has been conducted using the UK Biobank Resource under Application Number 35605. LP is supported by a grant from the National Health Association, Norway. MSA is supported by a grant from the South Eastern Regional Health Authority, Norway. KS is supported by a postdoctoral fellowship from the Canada First Research Excellence Fund (CFREF), awarded to McGill University for the Healthy Brains for Healthy Lives initiative (HBHL). ZGO is supported by the Fonds de recherche du Quebec Sante (FRQS) Chercheurs boursiers award, in collaboration with Parkinson Quebec, and by the Young Investigator Award by Parkinson Canada.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Study protocols were approved by the MUHC REB (IRB00010120) and all participants signed informed consent before entering the study.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Code used for the analysis can be found at https://github.com/gan-orlab/. Summary statistics are included in the supplementary files. All other data is available upon request.

https://github.com/gan-orlab/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted November 03, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Fine mapping of the HLA locus in Parkinson’s disease in Europeans
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Fine mapping of the HLA locus in Parkinson’s disease in Europeans
Eric Yu, Aditya Ambati, Maren Stolp Andersen, Lynne Krohn, Mehrdad A. Estiar, Prabhjyot Saini, Konstantin Senkevich, Yuri L. Sosero, Ashwin Ashok Kumar Sreelatha, Jennifer A. Ruskey, Farnaz Asayesh, Dan Spiegelman, Mathias Toft, Marte K. Viken, the International Parkinson’s Disease Genomics Consortium (IPDGC), Manu Sharma, Cornelis Blauwendraat, Lasse Pihlstrøm, Emmanuel Mignot, Ziv Gan-Or
medRxiv 2020.10.29.20217059; doi: https://doi.org/10.1101/2020.10.29.20217059
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Fine mapping of the HLA locus in Parkinson’s disease in Europeans
Eric Yu, Aditya Ambati, Maren Stolp Andersen, Lynne Krohn, Mehrdad A. Estiar, Prabhjyot Saini, Konstantin Senkevich, Yuri L. Sosero, Ashwin Ashok Kumar Sreelatha, Jennifer A. Ruskey, Farnaz Asayesh, Dan Spiegelman, Mathias Toft, Marte K. Viken, the International Parkinson’s Disease Genomics Consortium (IPDGC), Manu Sharma, Cornelis Blauwendraat, Lasse Pihlstrøm, Emmanuel Mignot, Ziv Gan-Or
medRxiv 2020.10.29.20217059; doi: https://doi.org/10.1101/2020.10.29.20217059

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (455)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (159)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5292)
  • Forensic Medicine (3)
  • Gastroenterology (198)
  • Genetic and Genomic Medicine (759)
  • Geriatric Medicine (80)
  • Health Economics (214)
  • Health Informatics (701)
  • Health Policy (361)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (165)
  • Infectious Diseases (except HIV/AIDS) (5925)
  • Intensive Care and Critical Care Medicine (366)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (772)
  • Nursing (43)
  • Nutrition (133)
  • Obstetrics and Gynecology (145)
  • Occupational and Environmental Health (234)
  • Oncology (481)
  • Ophthalmology (153)
  • Orthopedics (39)
  • Otolaryngology (97)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (137)
  • Primary Care Research (99)
  • Psychiatry and Clinical Psychology (865)
  • Public and Global Health (2034)
  • Radiology and Imaging (354)
  • Rehabilitation Medicine and Physical Therapy (159)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)